A weak summer could spell disaster for AC industry: Blue Star...
Blue Star MD B Thiagarajan sees strong growth in data centre projects, with an order book of ₹1,500 crore and a market opportunity of...
Cochin Shipyard signs $360 million mega deal with French firm CMA...
Shares of Cochin Shipyard Ltd ended at ₹1,529.60, up by ₹3.35, or 0.22%, on the BSE.Read More
BGR Energy Systems closes ₹634 crore Rajasthan VAT case; pays ₹29...
Shares of BGR Energy Systems Ltd ended at ₹346.65, up by ₹16.25, or 4.92%, on the BSE.Read More
Top Stories: AI ‘civilisational change’ debate, SarvamAI launch, Dr Reddy’s Canada...
Top 10@10 — CNBC-TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial highlights — delivered at 10...
Dr Reddy’s boosts gynaecology portfolio, acquires HRT brands from Mercury Pharma...
Dr Reddy's announced the acquisition of the trademarks Progynova and CycloProgynova and related assets in India from Mercury Pharma Group Ltd. Shares of Dr...
HUL approves ₹2,000-cr investment to expand premium beauty & well-being, home...
The investment aligns with HUL’s strategy of focusing on fewer, bigger bets and strengthening its presence in high-growth demand areas, including premium skin care,...
EU opens Legal Gateway office in India to boost tech talent...
The EU opened its first Legal Gateway office in India to connect EU and Indian ICT talent, led by Henna Virkkunen and S. Jaishankar....
CCI clears merger of Hinduja Leyland Finance into NDL Ventures
CCI approves merger of Hinduja Leyland Finance Limited into NDL Ventures Limited, consolidating HLFL’s vehicle and property lending business under NDL, which currently has...
Rising temperatures to boost Mother Dairy sales by 30% across key...
Mother Dairy expects 30% growth in ice creams, curd, and dairy beverages this summer, launching 30 new products and boosting capacity amid rising temperatures,...
Zydus Life gets FDA nod for children’s lung treatment drug bosentan
Zydus Lifesciences Ltd received US FDA approval for bosentan tablets for oral suspension, 32 mg, for pulmonary arterial hypertension (PAH) treatment. Shares of Zydus...
